Recombinant Human PF4V1 Protein，His & GST

PF4V1, or Platelet Factor 4 Variant 1, is a protein that has garnered attention in recent years due to its significant role in various physiological and pathological processes. This protein is a member of the CXC chemokine family and plays a critical role in inflammation, angiogenesis, and immune responses. Studies have shown that PF4V1 is involved in the modulation of platelet activation and aggregation, which are vital processes in hemostasis and thrombosis. Research indicates that alterations in PF4V1 expression or function may be linked to cardiovascular diseases, suggesting its potential as a biomarker for these conditions. Moreover, PF4V1's involvement in tumor microenvironments has raised interest in its potential role in cancer progression and metastasis. Recent advancements in recombinant protein technology have enabled the production of PF4V1 for further investigation into its structural and functional characteristics. Researchers are particularly focused on understanding how PF4V1 interacts with its receptors and the downstream signaling pathways it influences. By elucidating these mechanisms, the scientific community hopes to identify therapeutic targets for various diseases, including inflammatory disorders and malignancies. Overall, the study of PF4V1 as a recombinant protein holds promise for both basic science and clinical applications, paving the way for novel interventions in diseases where this protein plays a pivotal role.